{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:57:29Z","timestamp":1772265449939,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1245\/s10434-024-16316-3","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T20:19:25Z","timestamp":1728764365000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection"],"prefix":"10.1245","volume":"32","author":[{"given":"Yael","family":"Feferman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floris S.","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana M.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil P.","family":"Pappou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris H.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Widmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett M.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip B.","family":"Paty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Joshua","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rona","family":"Yaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil H.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Romesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard B.","family":"Saltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Garcia-Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"key":"16316_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.6004\/jnccn.2020.0032","volume":"18","author":"AB Benson","year":"2020","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: rectal cancer, version 6.2020. J Natl Compr Canc Netw. 2020;18:806\u201315. https:\/\/doi.org\/10.6004\/jnccn.2020.0032.","journal-title":"J Natl Compr Canc Netw."},{"key":"16316_CR2","first-page":"989","volume":"24","author":"WE Miles","year":"1931","unstructured":"Miles WE. The present position of the radical abdomino-perineal operation for cancer of the rectum in regard to mortality and post-operative recurrence. Proc R Soc Med. 1931;24:989\u201391.","journal-title":"Proc R Soc Med."},{"key":"16316_CR3","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114\u201323. https:\/\/doi.org\/10.1056\/NEJMoa060829.","journal-title":"N Engl J Med."},{"key":"16316_CR4","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJM199704033361402","volume":"336","author":"B Cedermark","year":"1997","unstructured":"Cedermark B, Dahlberg M, Glimelius B, Pahlman L, Rutqvist LE, Wilking N. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980\u20137. https:\/\/doi.org\/10.1056\/NEJM199704033361402.","journal-title":"N Engl J Med."},{"key":"16316_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10434-001-0163-9","volume":"8","author":"B Kuvshinoff","year":"2001","unstructured":"Kuvshinoff B, Maghfoor I, Miedema B, Bryer M, Westgate S, Wilkes J, Ota D. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or\u2009=\u20091 cm distal margins sufficient? Ann Surg Oncol. 2001;8:163\u20139. https:\/\/doi.org\/10.1007\/s10434-001-0163-9.","journal-title":"Ann Surg Oncol."},{"key":"16316_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1245\/aso.2003.04.010","volume":"10","author":"HG Moore","year":"2003","unstructured":"Moore HG, Riedel E, Minsky BD, et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol. 2003;10:80\u20135. https:\/\/doi.org\/10.1245\/aso.2003.04.010.","journal-title":"Ann Surg Oncol."},{"key":"16316_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00000658-198308000-00008","volume":"198","author":"WG Pollett","year":"1983","unstructured":"Pollett WG, Nicholls RJ. The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg. 1983;198:159\u201363. https:\/\/doi.org\/10.1097\/00000658-198308000-00008.","journal-title":"Ann Surg."},{"key":"16316_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/bjs.1800700305","volume":"70","author":"NS Williams","year":"1983","unstructured":"Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients\u2019 survival. Br J Surg. 1983;70:150\u20134. https:\/\/doi.org\/10.1002\/bjs.1800700305.","journal-title":"Br J Surg."},{"key":"16316_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(00)04040-x","volume":"357","author":"RG Beets-Tan","year":"2001","unstructured":"Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 2001;357:497\u2013504. https:\/\/doi.org\/10.1016\/s0140-6736(00)04040-x.","journal-title":"Lancet."},{"key":"16316_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/bjs.5917","volume":"95","author":"NJ Smith","year":"2008","unstructured":"Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg. 2008;95:229\u201336. https:\/\/doi.org\/10.1002\/bjs.5917.","journal-title":"Br J Surg."},{"key":"16316_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/SLA.0b013e318195e17c","volume":"249","author":"MR Weiser","year":"2009","unstructured":"Weiser MR, Quah HM, Shia J, et al. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg. 2009;249:236\u201342. https:\/\/doi.org\/10.1097\/SLA.0b013e318195e17c.","journal-title":"Ann Surg."},{"key":"16316_CR12","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/s00268-009-0079-2","volume":"33","author":"N Saito","year":"2009","unstructured":"Saito N, Sugito M, Ito M, et al. Oncologic outcome of intersphincteric resection for very low rectal cancer. World J Surg. 2009;33:1750\u20136. https:\/\/doi.org\/10.1007\/s00268-009-0079-2.","journal-title":"World J Surg."},{"key":"16316_CR13","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/DCR.0000000000001155","volume":"61","author":"S Tsukamoto","year":"2018","unstructured":"Tsukamoto S, Miyake M, Shida D, Ochiai H, Yamada K, Kanemitsu Y. Intersphincteric resection has similar long-term oncologic outcomes compared with abdominoperineal resection for low rectal cancer without preoperative therapy: results of propensity score analyses. Dis Colon Rectum. 2018;61:1035\u201342. https:\/\/doi.org\/10.1097\/DCR.0000000000001155.","journal-title":"Dis Colon Rectum."},{"key":"16316_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1200\/jco.23.01208","volume":"42","author":"FS Verheij","year":"2024","unstructured":"Verheij FS, Omer DM, Williams H, et al. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol. 2024;42:500\u20136. https:\/\/doi.org\/10.1200\/jco.23.01208.","journal-title":"J Clin Oncol."},{"key":"16316_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.6004\/jnccn.2014.0056","volume":"12","author":"A Cercek","year":"2014","unstructured":"Cercek A, Goodman KA, Hajj C, et al. Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Canc Netw. 2014;12:513\u20139. https:\/\/doi.org\/10.6004\/jnccn.2014.0056.","journal-title":"J Natl Compr Canc Netw."},{"key":"16316_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0071","volume":"4","author":"A Cercek","year":"2018","unstructured":"Cercek A, Roxburgh CSD, Strombom P, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;4:e180071. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0071.","journal-title":"JAMA Oncol."},{"key":"16316_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5896","volume":"5","author":"JJ Smith","year":"2019","unstructured":"Smith JJ, Strombom P, Chow OS, et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 2019;5:e185896. https:\/\/doi.org\/10.1001\/jamaoncol.2018.5896.","journal-title":"JAMA Oncol."},{"key":"16316_CR18","first-page":"335","volume":"181","author":"WE Enker","year":"1995","unstructured":"Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181:335\u201346.","journal-title":"J Am Coll Surg."},{"key":"16316_CR19","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/archsurg.133.8.894","volume":"133","author":"RJ Heald","year":"1998","unstructured":"Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978\u20131997. Arch Surg. 1998;133:894\u20139. https:\/\/doi.org\/10.1001\/archsurg.133.8.894.","journal-title":"Arch Surg."},{"key":"16316_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"key":"16316_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin."},{"key":"16316_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/cncr.23516","volume":"113","author":"HM Quah","year":"2008","unstructured":"Quah HM, Chou JF, Gonen M, et al. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer. 2008;113:57\u201364. https:\/\/doi.org\/10.1002\/cncr.23516.","journal-title":"Cancer."},{"issue":"10","key":"16316_CR23","doi-asserted-by":"publisher","first-page":"dju248","DOI":"10.1093\/jnci\/dju248","volume":"106","author":"A Trakarnsanga","year":"2014","unstructured":"Trakarnsanga A, Gonen M, Shia J, et al. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst. 2014;106(10):dju248. https:\/\/doi.org\/10.1093\/jnci\/dju248.","journal-title":"J Natl Cancer Inst."},{"key":"16316_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.14216\/kjco.21012","volume":"17","author":"WI Jo","year":"2021","unstructured":"Jo WI, Lim DR, Kuk JC, Shin EJ. Comparison of oncologic outcome of abdominoperineal resection versus sphincter saving resection for low lying rectal cancer. Korean J Clin Oncol. 2021;17:73\u201381. https:\/\/doi.org\/10.14216\/kjco.21012.","journal-title":"Korean J Clin Oncol."},{"key":"16316_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11605-016-3339-0","volume":"21","author":"J Klose","year":"2017","unstructured":"Klose J, Tarantino I, Kulu Y, et al. Sphincter-preserving surgery for low rectal cancer: do we overshoot the mark? J Gastrointest Surg. 2017;21:885\u201391. https:\/\/doi.org\/10.1007\/s11605-016-3339-0.","journal-title":"J Gastrointest Surg."},{"issue":"Suppl 3","key":"16316_CR26","doi-asserted-by":"publisher","first-page":"S422","DOI":"10.1245\/s10434-014-3573-1","volume":"21","author":"M Koyama","year":"2014","unstructured":"Koyama M, Murata A, Sakamoto Y, Morohashi H, Takahashi S, Yoshida E, Hakamada K. Long-term clinical and functional results of intersphincteric resection for lower rectal cancer. Ann Surg Oncol. 2014;21(Suppl 3):S422-428. https:\/\/doi.org\/10.1245\/s10434-014-3573-1.","journal-title":"Ann Surg Oncol."},{"key":"16316_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008249","volume":"96","author":"SS Yeom","year":"2017","unstructured":"Yeom SS, Park IJ, Jung SW, et al. Outcomes of patients with abdominoperineal resection (APR) and low anterior resection (LAR) who had very low rectal cancer. Medicine (Baltimore). 2017;96:e8249. https:\/\/doi.org\/10.1097\/MD.0000000000008249.","journal-title":"Medicine (Baltimore)."},{"key":"16316_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/1553350620918414","volume":"27","author":"B Peng","year":"2020","unstructured":"Peng B, Lu J, Wu Z, Li G, Wei F, Cao J, Li W. Intersphincteric resection versus abdominoperineal resection for low rectal cancer: a meta-analysis. Surg Innov. 2020;27:392\u2013401. https:\/\/doi.org\/10.1177\/1553350620918414.","journal-title":"Surg Innov."},{"key":"16316_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00384-019-03267-5","volume":"34","author":"AC Fields","year":"2019","unstructured":"Fields AC, Scully RE, Saadat LV, et al. Oncologic outcomes for low rectal adenocarcinoma following low anterior resection with coloanal anastomosis versus abdominoperineal resection: a National Cancer Database propensity matched analysis. Int J Colorectal Dis. 2019;34:843\u20138. https:\/\/doi.org\/10.1007\/s00384-019-03267-5.","journal-title":"Int J Colorectal Dis."},{"key":"16316_CR30","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/codi.15258","volume":"22","author":"Q Denost","year":"2020","unstructured":"Denost Q, Moreau JB, Vendrely V, Celerier B, Rullier A, Assenat V, Rullier E. Intersphincteric resection for low rectal cancer: the risk is functional rather than oncological. A 25-year experience from Bordeaux. Colorectal Dis. 2020;22:1603\u201313. https:\/\/doi.org\/10.1111\/codi.15258.","journal-title":"Colorectal Dis."},{"key":"16316_CR31","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/DCR.0000000000001321","volume":"62","author":"JS Park","year":"2019","unstructured":"Park JS, Park SY, Kim HJ, Cho SH, Kwak SG, Choi GS. Long-term oncologic outcomes after neoadjuvant chemoradiation followed by intersphincteric resection with coloanal anastomosis for locally advanced low rectal cancer. Dis Colon Rectum. 2019;62:408\u201316. https:\/\/doi.org\/10.1097\/DCR.0000000000001321.","journal-title":"Dis Colon Rectum."},{"key":"16316_CR32","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","volume":"11","author":"M Maas","year":"2010","unstructured":"Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11:835\u201344. https:\/\/doi.org\/10.1016\/S1470-2045(10)70172-8.","journal-title":"Lancet Oncol."},{"key":"16316_CR33","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40:2546\u201356. https:\/\/doi.org\/10.1200\/JCO.22.00032.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16316-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16316-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16316-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:04:56Z","timestamp":1734631496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16316-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["16316"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16316-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Julio Garcia-Aguilar owns stock in Intuitive Surgical. J. Joshua Smith received travel support for fellow education from Intuitive Surgical (August 2015); served as a clinical advisor for Guardant Health (March 2019) and as a clinical advisor for Foundation Medicine (April 2022); served as a consultant and speaker for Johnson and Johnson (May 2022); and serves as a clinical advisor and consultant for GlaxoSmithKline (2023\u20132024). Andrea Cercek declares research funding from GSK and Seagen, and advisory board participation for Roche, Pfizer, GSK Merck, Seagen, Janssen, Illumina, Amgen, and Abbvie. Neil Segal declares consulting\/advisory board participation for Agenus, Regeneron, Puretech, Novartis, Numab, and AstraZeneca; research funding from Roche\/Genentech, Pfizer, Merck, BMS, AstraZeneca, Puretech, Immunocore, Regeneron, and Agenus; and travel support\u00a0from AstraZeneca and Regeneron. Paul B. Romesser has received research funding from EMD Serono and XRad Therapeutics; serves as a consultant for Faeth Therapeutics and Natera; and is a member of the advisory boards of the HPV Cancers Alliance and Anal Cancer Foundation. Yael Feferman, Floris S. Verheij, Hannah Williams, Dana M. Omer, Emmanouil P. Pappou, Iris H. Wei, Maria Widmar, Garrett M. Nash, Philip B. Paty, Rona Yaeger, Christopher Crane, Leonard B. Saltz, and Martin R. Weiser have no disclosures to declare that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}